MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Association between changes in hippocampal volumes, cognition, and CSF markers in Parkinson’s Disease

    S. Becker, O. Granert, C. Schulte, K. Brockmann, B. Roeben, M. Bode, M. Timmers, K. Scheffler, W. Maetzler, D. Berg, I. Liepelt-Scarfone (Calgary, Canada)

    Objective: To assess whether changes in hippocampal subfield volumes are associated with cognition or CSF β-amyloid 1–42 (Aβ42) levels in Parkinson’s Disease (PD). Background: Hippocampal…
  • 2023 International Congress

    Visuo-spatial processing is linked to cortical glutamate dynamics in Parkinson’s disease – a 7 Tesla functional MRS study

    A. Ophey, E. Farrher, N. Pagel, A. Seger, C. Doppler, N. Shah, E. Kalbe, G. Fink, M. Sommerauer (Cologne, Germany)

    Objective: To investigate alterations of glutamate metabolism in the occipital cortex during visual processing in patients with Parkinson’s disease (PD). Background: Cognitive decline is a…
  • 2023 International Congress

    Management of constipation in Parkinson’s patients presenting with acute sigmoid volvulus to Royal Berkshire Hospital,Reading, UK

    M. Khwaja, S. Alam, E. Castaneda-Caicedo, A. Chatterjee (Reading, United Kingdom)

    Objective: To evaluate management of constipation in acute sigmoid volvulus in Parkinson’s. Background: Constipation is one of the main and disabling non motor symptoms in…
  • 2023 International Congress

    Plasma glucosylsphingosine in GBA1 E326K, N370S and L444P mutation carriers with and without Parkinson’s disease

    A. Haimovich, J. Agin-Liebes, N. Hatcher, L. Yao, C. Waters, R. Alcalay (New York, USA)

    Objective: To measure plasma glucosylsphingosine levels in heterozygous carriers with and without Parkinson's disease (PD) of three variants in GBA1: 1. E326K (risk factor for…
  • 2023 International Congress

    Living with Parkinson’s disease scale: First validation study among English-speaking population

    L. Ambrosio, K. Hislop-Lennie, N. Serrano-Fuentes, C. Driessens, MC. Portillo (Southampton, United Kingdom)

    Objective: To analyse the psychometric properties of the English version of the Living with long term conditions (LwLTCs) scale in people living with Parkinson’s disease…
  • 2023 International Congress

    Intrarater and interrater reliability of the 3 meter backward walk test in individuals with Parkinson disease.

    A. Boddy, K. Barta, L. Perry, M. Flores, K. Sawyer, A. Campbell (St Augustine, USA)

    Objective: Determine the intrarater and interrater reliability of the three meter backward walk (3 MBW) test for individuals diagnosed with Parkinson Disease. Background: Background- Parkinson…
  • 2023 International Congress

    Stability and predictability of motor symptom control in patients with advanced Parkinson’s disease (aPD) receiving continuous subcutaneous foslevodopa/foscarbidopa (LDP/CDP)

    R. Pahwa, I. Malaty, M. Soileau, V. Fung, D. Santos Garcia, C. Carroll, T. Henriksen, A. Epstein, C. Yan, A. Alobaidi, A. Shewale, A. Spiegel, M. Facheris, M. Shah, P. Kukreja, J. Zamudio, K. Chaudhuri (Kansas City, USA)

    Objective: To evaluate temporal changes in motor states (OFF and ON without troublesome dyskinesia [TD; good ON]) throughout the waking day in patients with aPD…
  • 2023 International Congress

    Case report on the use of a High Frequency Vibrotactile Stimulation and Cueing Device over 4 months in a patient with Parkinson’s Disease and refractory symptoms

    A. Mackett (Cambridge, United Kingdom)

    Objective: To document motor symptoms of a patient with PD whilst using a Focussed Vibrotactile Stimulation and Cueing Device (FVCD). Background: A 77-year-old patient with…
  • 2023 International Congress

    A Need for Improving the Diet Quality of Individuals with Parkinson’s Disease

    S. Mandali, K. Lyons, R. Pahwa, A. Lee (Kansas City, USA)

    Objective: This is a quality improvement project undertaken with an aim to evaluate the diet quality and adherence to the Mediterranean diet among individuals with…
  • 2023 International Congress

    Practices of neurologists in the management of Parkinson’s disease patients in the Republic of Moldova

    L. Rotaru, O. Grosu (Chisinau, Republic of Moldova)

    Objective: The aim of the study was to analyze practices of Moldovan neurologists regarding the management of Parkinson’s disease patients. Background: Parkinson’s disease management depends…
  • « Previous Page
  • 1
  • …
  • 265
  • 266
  • 267
  • 268
  • 269
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley